Nearly all staff are vaccinated in majority of Connecticut’s long-term care facilities
By
Alicia Lasek
Oct 19, 2021
One state is experiencing success with its COVID-19 vaccination mandate: Fully three quarters of LTC facilities in Connecticut have a 95% staff vaccination rate, its Department of Public Health announced...
Most post-acute Medicare recipients with dementia sent to SNFs despite payment changes: study
By
Alicia Lasek
Oct 15, 2021
Investigators were surprised to find that post-acute care use patterns remained stable after major payment reform initiatives. Beneficiaries with dementia were sent to skilled nursing facilities more often...
FDA advisers recommend Moderna COVID booster for seniors, others at high risk
By
Alicia Lasek
Oct 15, 2021
In a unanimous vote, advisers agreed that vulnerable Moderna vaccine recipients should be offered a third shot. A half dose will be effective and will help protect against side effects, the drugmaker says.
Validated list of key drug-drug interactions that affect older adults published
By
Alicia Lasek
Oct 14, 2021
The list, published Wednesday in JAMDA, includes 66 drug-drug interactions that are commonly problematic for older adults, and can be used as a clinical management tool to assess potential harms.
Nursing home residents may have better CPR outcomes than their community-dwelling peers: study
By
Alicia Lasek
Oct 14, 2021
Withholding vigorous treatment for cardiac arrest solely based on nursing home residential status is not justified, researchers say.
Clinical briefs for Thursday, Oct. 14
By
Alicia Lasek
Oct 14, 2021
New CDC effort will track impact of COVID-19 and other public health threats on long-term care facilities … FDA pushes to cut sodium by 12% in American foods in bid to confront chronic disease epidemic...
LeadingAge releases booster shot toolkit for senior living, home care settings
By
Alicia Lasek
Oct 06, 2021
The kit provides links to sources of support for on-site booster clinic set-up and guidance for administrators who must encourage off-site vaccine access.
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.
No unexpected pattern of adverse booster shot reactions reported by CDC app users
By
Alicia Lasek
Sep 30, 2021
Most v-safe app respondents reported mild to moderate, transient reactions, usually the day after vaccination, CDC investigators say. Sixty percent of respondents were between the ages of 50 and 74.